AFP and metabolic dysfunction-associated steatotic liver disease: There was no difference in age, blood type, insulin-dependence, listing AFP, or listing tumor burden, although NAFLD+obese-HCC patients had higher listing MELD-Na (12 versus 10, P < 0.001) and fewer LRT (P = 0.03).